Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
Pulse Biosciences, Inc. (Nasdaq: PLSE) , a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ ...
Medtronic targets $1B cardiovascular growth in FY25 with PFA expansion
Q3 2025 Management View CEO Geoff Martha highlighted mid-single-digit revenue growth for the ninth consecutive quarter, driven by strong performances in cardiac ablation solutions, leadless pacing, ...